Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-20T11:44:37.342Z Has data issue: false hasContentIssue false

7 - Portal Hypertension

from SECTION I - PATHOPHYSIOLOGY OF PEDIATRIC LIVER DISEASE

Published online by Cambridge University Press:  18 December 2009

By
Benjamin L. Shneider M.D.
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Benjamin L. Shneider M.D.
Affiliation:
Visiting Professor, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania; Director of Pediatric Hepatology, Department of Pediatrics/Gastroenterology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
Frederick J. Suchy
Affiliation:
Mount Sinai School of Medicine, New York
Ronald J. Sokol
Affiliation:
University of Colorado, Denver
William F. Balistreri
Affiliation:
University of Cincinnati
Get access

Summary

A portal system is one, which by definition, begins and ends with capillaries. The major portal system in humans is one in which the capillaries originate in the mesentery of the intestines and spleen and end in the hepatic sinusoids. Capillaries of the superior mesenteric and splenic veins supply the portal vein with a nutrient- and hormone-rich blood supply (Figure 7.1). The partially oxygenated portal venous blood supplements the oxygenated hepatic arterial flow to give the liver unique protection against hypoxia. Blood flow from the hepatic artery and portal vein is well coordinated to maintain consistent flow and explains the ability of the liver to withstand thrombosis of either of these major vascular structures. This well-regulated blood flow in conjunction with the very low resistance found in the portal system results in a low baseline portal pressure in healthy individuals.

Portal hypertension, defined as an elevation of portal blood pressure above 5 mm Hg, is one of the major causes of morbidity and mortality in children with liver disease (Table 7.1). The high prevalence of biliary tract disease in pediatric liver disorders (e.g., biliary atresia), as compared with adult liver disorders, predisposes to the expression of portal hypertension earlier in the clinical course of liver disease relative to the manifestation of the sequelae of hepatic insufficiency. Portal hypertension is a complication of a wide variety of pediatric liver disorders (Table 7.1). Its complications are some of the leading indications for liver transplantation.

Type
Chapter
Information
Liver Disease in Children , pp. 138 - 162
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Goncalves, M E, Cardoso, S R, Maksoud, J G. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. J Pediatr Surg 2000;35:401–5.CrossRefGoogle ScholarPubMed
Zargar, S A, Javid, G, Khan, B A. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction. Hepatology 2002;36:666–72.CrossRefGoogle ScholarPubMed
Shneider, B. Approaches to the management of pediatric portal hypertension: Results of an informal survey. In: Groszmann, R, Tygat, N, Bosch, J, eds. Portal hypertension in the 21st century. Boston: Kluwer Academic Publishers, 2004.Google Scholar
Ohllson, E, Rutherford, R, Boitnott, J. Changes in portal circulation after biliary obstruction in dogs. Am J Surg 1970;120:16–22.CrossRefGoogle Scholar
Chojkier, M, Groszmann, R J. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol 1981;240:G371–5.Google ScholarPubMed
Okudaira, M, Kume, H, Ohku, M. Experimental portal fibrosis induced by chronic feeding of aflatoxin-B1. In: Sarin, S K, ed. Animal models of portal hypertension. New Delhi: Kunj Publishing, 1988:135–41.Google Scholar
Sarin, S K, Groszmann, R, Mosca, P G. Propranalol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 1991;87:1032–6.CrossRefGoogle Scholar
Vorobioff, J, Bredfeldt, J E, Groszmann, R J. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984;87:1120–6.Google ScholarPubMed
Iwakiri, Y, Cadelina, G, Sessa, W C, Groszmann, R J. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. Am J Physiol Gastrointest Liver Physiol 2002;283:G1074–81.CrossRefGoogle ScholarPubMed
Biecker, E, Neef, M, Sagesser, H. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int 2004;24:345–53.CrossRefGoogle ScholarPubMed
McIndoe, A. Vascular lesions of portal cirrhosis. Arch Pathol 1928;5:23–32.Google Scholar
Kowalski, H J, Abelmann, W H. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953;32:1025–33.CrossRefGoogle ScholarPubMed
Janssen, H L, Garcia-Pagan, J C, Elias, E. Budd–Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364–71.CrossRefGoogle ScholarPubMed
Menon, K V, Shah, V, Kamath, P S. The Budd–Chiari syndrome. N Engl J Med 2004;350:578–85.CrossRefGoogle ScholarPubMed
Bayraktar, Y, Balkanci, F, Bayraktar, M, Calguneri, M. Budd–Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol 1997;92:858–62.Google ScholarPubMed
Gentil-Kocher, S, Bernard, O, Brunelle, F. Budd–Chiari syndrome in children: report of 22 cases. J Pediatr 1988;113(1 pt 1):30–8.CrossRefGoogle Scholar
Safouh, M, Shehata, A H. Hepatic vein occlusion disease of Egyptian children. J Pediatr 1965;67:415–22.CrossRefGoogle ScholarPubMed
Howard, E R, Stringer, M D, Mowat, A P. Assessment of injection sclerotherapy in the management of 152 children with oesophageal varices. Br J Surg 1988;75:404–8.CrossRefGoogle ScholarPubMed
Alvarez, F, Bernard, O, Brunelle, F. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr 1983;103:696–702.Google ScholarPubMed
Ahuja, V, Marwaha, N, Chawla, Y, Dilawari, J B. Coagulation abnormalities in idiopathic portal venous thrombosis. J Gastroenterol Hepatol 1999;14:1210–11.CrossRefGoogle ScholarPubMed
Denninger, M H, Chait, Y, Casadevall, N. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587–91.CrossRefGoogle ScholarPubMed
Gauthier-Villars, M, Franchi, S, Gauthier, F. Cholestasis in children with portal vein obstruction. J Pediatr 2005;146:568–73.CrossRefGoogle ScholarPubMed
Sutton, J P, Yarborough, D Y, Richards, J T. Isolated splenic vein occlusion. Review of literature and report of an additional case. Arch Surg 1970;100:623–6.Google ScholarPubMed
Colman, J C, Britton, R S, Orrego, H. Relation between osmotically induced hepatocyte enlargement and portal hypertension. Am J Physiol 1983;245:G382–7.Google ScholarPubMed
Orrego, H, Blendis, L M, Crossley, I R. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat. Gastroenterology 1981;80:546–56.Google ScholarPubMed
Miga, D, Sokol, R J, Mackenzie, T. Survival after first esophageal variceal hemorrhage in patients with biliary atresia. J Pediatr 2001;139:291–6.CrossRefGoogle ScholarPubMed
D'Amico, G, Franchis, R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599–612.Google ScholarPubMed
Durie, P R, Kent, G, Phillips, M J, Ackerley, C A. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol 2004;164:1481–93.CrossRefGoogle Scholar
Moser, M, Matthiesen, S, Kirfel, J. A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD). Hepatology 2005;41:1113–21.CrossRefGoogle Scholar
McCright, B, Lozier, J, Gridley, T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002;129:1075–82.Google ScholarPubMed
Smit, J J, Schinkel, A H, Oude Elferink, R P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451–62.CrossRefGoogle ScholarPubMed
Gupta, T K, Toruner, M, Chung, M K, Groszmann, R J. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998;28:926–31.CrossRefGoogle ScholarPubMed
Dudenhoefer, A A, Loureiro-Silva, M R, Cadelina, G W. Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers. Hepatology 2002;36:381–5.CrossRefGoogle ScholarPubMed
Zafra, C, Abraldes, J G, Turnes, J. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology 2004;126:749–55.CrossRefGoogle ScholarPubMed
Moore, K, Wendon, J, Frazer, M. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992;327:774–8.CrossRefGoogle ScholarPubMed
Martinet, J P, Legault, L, Cernacek, P. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 1996;25:700–6.CrossRefGoogle ScholarPubMed
Rockey, D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997;25:2–5.CrossRefGoogle ScholarPubMed
Kaneda, K, Ekataksin, W, Sogawa, M. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 1998;27:735–47.CrossRefGoogle ScholarPubMed
Kojima, H, Yamao, J, Tsujimoto, T. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance. J Hepatol 2000;32:43–50.CrossRefGoogle ScholarPubMed
Donovan, A, Reynolds, T, Mikkelson, W. Systemic-portal arteriovenous fistulas: pathologic and hemodynamic observations in two patients. Surgery 1969;66:474–82.Google Scholar
Griner, P, Elbadani, A, Packman, C. Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Ann Intern Med 1976;85:578–82.CrossRefGoogle ScholarPubMed
Maksoud, J G, Mies, S, da Costa Gayotto, L C. Hepatoportal sclerosis in childhood. Am J Surg 1986;151:484–8.CrossRefGoogle ScholarPubMed
Sperl, W, Stuppner, H, Gassner, I. Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. Eur J Pediatr 1995;154:112–6.CrossRefGoogle Scholar
Corbacioglu, S, Greil, J, Peters, C. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004;33:189–95.CrossRefGoogle ScholarPubMed
Okuda, K, Kono, K, Ohnishi, K. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 1984;86:600–10.Google ScholarPubMed
Bioulac-Sage, P, Bail, B, Bernard, P H, Balabaud, C. Hepatoportal sclerosis. Semin Liver Dis 1995;15:329–39.CrossRefGoogle ScholarPubMed
Schwerdtfeger, E, Abdel-Rahim, I, Kardoff, R. Ultrasonic invesigation of periportal fibrosis in children with Schistoma mansoni infection: reversibility of morbidity twenty-three years after treatment with praziquantel. Am J Trop Med Hyg 1992;46:409–15.CrossRefGoogle Scholar
Vorobioff, J, Bredfeldt, J E, Groszmann, R J. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983;244:G52–7.Google ScholarPubMed
Benoit, J N, Barrowman, J A, Harper, S L. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol 1984;247(5 pt 1):G486–93.Google Scholar
Sikuler, E, Groszmann, R J. Hemodynamic studies in a parabiotic model of portal hypertension. Experientia 1985;41:1323–4.CrossRefGoogle Scholar
Silva, G, Navasa, M, Bosch, J. Hemodynamic effects of glucagon in portal hypertension. Hepatology 1990;11:668–73.CrossRefGoogle ScholarPubMed
Kvietys, P R, McLendon, J M, Granger, D N. Postprandial intestinal hyperemia: role of bile salts in the ileum. Am J Physiol 1981;241:G469–77.Google ScholarPubMed
Genecin, P, Polio, J, Colombato, L A. Bile acids do not mediate the hyperdynamic circulation in portal hypertensive rats. Am J Physiol 1990;259(1 pt 1):G21–5.Google Scholar
Thomas, S H, Joh, T, Benoit, J N. Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension. Dig Dis Sci 1991;36:1243–8.CrossRefGoogle ScholarPubMed
Sitzmann, J V, Bulkley, G B, Mitchell, M C, Campbell, K. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg 1989;209:322–7.CrossRefGoogle ScholarPubMed
Lee, S S, Chilton, E L, Pak, J M. Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats. Hepatology 1992;15:1107–11.CrossRefGoogle ScholarPubMed
Moller, S, Bendtsen, F, Schifter, S, Henriksen, J H. Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis. Scand J Gastroenterol 1996;31:928–33.CrossRefGoogle ScholarPubMed
Fernandez, M, Bonkovsky, H L. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999;29:1672–9.CrossRefGoogle ScholarPubMed
Batkai, S, Jarai, Z, Wagner, J A. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001;7:827–32.CrossRefGoogle Scholar
Ros, J, Claria, J, To-Figueras, J. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 2002;122:85–93.CrossRefGoogle ScholarPubMed
Pizcueta, M P, Pique, J M, Bosch, J. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992;105:184–90.CrossRefGoogle ScholarPubMed
Sieber, C C, Groszmann, R J. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992;262(6 pt 1):G996–1001.Google Scholar
Tsai, M H, Iwakiri, Y, Cadelina, G. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology 2003;125:1452–61.CrossRefGoogle ScholarPubMed
Lopez-Talavera, J C, Cadelina, G, Olchowski, J. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 1996;23:1616–21.Google ScholarPubMed
Genecin, P, Polio, J, Groszmann, R J. Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension. Am J Physiol 1990;259(3 pt 1):G498–503.Google ScholarPubMed
Willett, I R, Esler, M, Jennings, G, Dudley, F J. Sympathetic tone modulates portal venous pressure in alcoholic cirrhosis. Lancet 1986;2:939–43.CrossRefGoogle ScholarPubMed
Mastai, R, Rocheleau, B, Huet, P M. Serotonin blockade in conscious, unrestrained cirrhotic dogs with portal hypertension. Hepatology 1989;9:265–8.CrossRefGoogle ScholarPubMed
Pinkerton, J A, Holcomb, G W, Foster, J H. Portal hypertension in childhood. Ann Surg 1972;175:870–86.CrossRefGoogle ScholarPubMed
Spence, R A, Johnston, G W, Odling-Smee, G W, Rodgers, H W. Bleeding oesophageal varices with long term follow up. Arch Dis Child 1984;59:336–40.CrossRefGoogle ScholarPubMed
Garcia-Pagan, J C, Feu, F, Castells, A. Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis. Hepatology 1994;19:595–601.CrossRefGoogle ScholarPubMed
Chen, L, Groszmann, R J. Blood in the gastric lumen increases splanchnic blood flow and portal pressure in portal-hypertensive rats. Gastroenterology 1996;111:1103–10.CrossRefGoogle ScholarPubMed
Lee, S S, Hadengue, A, Moreau, R. Postprandial hemodynamic responses in patients with cirrhosis. Hepatology 1988;8:647–51.CrossRefGoogle ScholarPubMed
Garcia-Pagan, J C, Santos, C, Barbera, J A. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996;111:1300–6.CrossRefGoogle ScholarPubMed
Webb, L J, Sherlock, S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 1979;48:627–39.Google ScholarPubMed
Shah, S H, Hayes, P C, Allan, P L. Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol 1996;91:2580–3.Google ScholarPubMed
Westaby, S, Wilkinson, S P, Warren, R, Williams, R. Spleen size and portal hypertension in cirrhosis. Digestion 1978;17:63–8.CrossRefGoogle ScholarPubMed
Yachha, S K, Dhiman, R K, Gupta, R, Ghoshal, U C. Endosonographic evaluation of the rectum in children with extrahepatic portal venous obstruction. J Pediatr Gastroenterol Nutr 1996;23:438–41.CrossRefGoogle ScholarPubMed
Weinberg, G D, Matalon, T A, Brunner, M C. Bleeding stomal varices: treatment with a transjugular intrahepatic portosystemic shunt in two pediatric patients. J Vasc Interv Radiol 1995;6:233–6.CrossRefGoogle ScholarPubMed
Fallon, M B, Abrams, G A, Luo, B. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997;113:606–14.CrossRefGoogle ScholarPubMed
Zhang, M, Luo, B, Chen, S J. Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol 1999;277(5 pt 1):G944–52.Google Scholar
Shah, V, Kamath, P S. Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl 2003;9:1–11.CrossRefGoogle ScholarPubMed
Hoeper, M M, Krowka, M J, Strassburg, C P. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004;363:1461–8.CrossRefGoogle ScholarPubMed
Fallon, M B. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol 2005;39(4 suppl 2):S138–42.CrossRefGoogle Scholar
Kinane, T B, Westra, S J. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31–2004. A four-year-old boy with hypoxemia. N Engl J Med 2004;351: 1667–75.Google ScholarPubMed
Abrams, G A, Jaffe, C C, Hoffer, P B. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109: 1283–8.CrossRefGoogle ScholarPubMed
Santamaria, F, Sarnelli, P, Celentano, L. Noninvasive investigation of hepatopulmonary syndrome in children and adolescents with chronic cholestasis. Pediatr Pulmonol 2002;33:374–9.CrossRefGoogle ScholarPubMed
Yonemura, T, Yoshibayashi, M, Uemoto, S. Intrapulmonary shunting in biliary atresia before and after living-related liver transplantation. Br J Surg 1999;86:1139–43.CrossRefGoogle ScholarPubMed
Barbe, T, Losay, J, Grimon, G. Pulmonary arteriovenous shunting in children with liver disease. J Pediatr 1995;126:571–9.CrossRefGoogle ScholarPubMed
Caldwell, S H, Jeffers, L J, Narula, O S. Ancient remedies revisited: does Allium sativum (garlic) palliate the hepatopulmonary syndrome?J Clin Gastroenterol 1992;15:248–50.CrossRefGoogle ScholarPubMed
Abrams, G A, Nanda, N C, DubovskyEV, et al EV, et al. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998;114:305–10.CrossRefGoogle ScholarPubMed
Lange, P A, Stoller, J K. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521–9.CrossRefGoogle ScholarPubMed
Krowka, M J, Cortese, D A. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994;105:1528–37.Google ScholarPubMed
Lebrec, D, Capron, J P, Dhumeaux, D, Benhamou, J P. Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis 1979;120:849–56.Google ScholarPubMed
Budhiraja, R, Hassoun, P M. Portopulmonary hypertension: a tale of two circulations. Chest 2003;123:562–76.CrossRefGoogle ScholarPubMed
Krowka, M J, Mandell, M S, Ramsay, M A. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004;10:174–82.CrossRefGoogle ScholarPubMed
Schuijtvlot, E T, Bax, N M, Houwen, R H, Hruda, J. Unexpected lethal pulmonary hypertension in a 5-year-old girl successfully treated for biliary atresia. J Pediatr Surg 1995;30:589–90.CrossRefGoogle Scholar
Soh, H, Hasegawa, T, Sasaki, T. Pulmonary hypertension associated with postoperative biliary atresia: report of two cases. J Pediatr Surg 1999;34:1779–81.CrossRefGoogle ScholarPubMed
Hoeper, M M, Halank, M, Marx, C. Bosentan therapy for portopulmonary hypertension. Eur Respir J 2005;25:502–8.CrossRefGoogle ScholarPubMed
Minder, S, Fischler, M, Muellhaupt, B. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension. Eur Respir J 2004;24:703–7.CrossRefGoogle ScholarPubMed
Halank, M, Kolditz, M, Miehlke, S. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan. Wien Med Wochenschr 2005;155:376–80.CrossRefGoogle ScholarPubMed
Makisalo, H, Koivusalo, A, Vakkuri, A, Hockerstedt, K. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Transpl 2004;10:945–50.CrossRefGoogle Scholar
Chua, R, Keogh, A, Miyashita, M. Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant 2005;24:498–500.CrossRefGoogle ScholarPubMed
Losay, J, Piot, D, Bougaran, J. Early liver transplantation is crucial in children with liver disease and pulmonary artery hypertension. J Hepatol 1998;28:337–42.CrossRefGoogle ScholarPubMed
Laving, A, Khanna, A, Rubin, L. Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol. J Pediatr Gastroenterol Nutr 2005;41:466–8.CrossRefGoogle Scholar
Pirenne, J, Verleden, G, Nevens, F. Combined liver and (heart-)lung transplantation in liver transplant candidates with refractory portopulmonary hypertension. Transplantation 2002;73:140–2.CrossRefGoogle ScholarPubMed
Albillos, A, Colombato, L A, Groszmann, R J. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992;102:931–5.CrossRefGoogle ScholarPubMed
Thalheimer, U, Triantos, C K, Samonakis, D N. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 2005;54: 556–63.CrossRefGoogle ScholarPubMed
Alessandria, C, Ozdogan, O, Guevara, M. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005;41:1282–9.CrossRefGoogle ScholarPubMed
Wong, F, Pantea, L, Sniderman, K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004;40:55–64.CrossRefGoogle ScholarPubMed
Ellis, D, Avner, E D. Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation. Clin Nephrol 1986;25:295–303.Google ScholarPubMed
Wood, R P, Ellis, D, Starzl, T E. The reversal of the hepatorenal syndrome in four pediatric patients following successful orthotopic liver transplantation. Ann Surg 1987;205:415–19.CrossRefGoogle ScholarPubMed
Mitra, S K, Kumar, V, Datta, D V. Extrahepatic portal hypertension: a review of 70 cases. J Pediatr Surg 1978;13:51–7.CrossRefGoogle ScholarPubMed
Sarin, S K, Agarwal, S R. Extrahepatic portal vein obstruction. Semin Liver Dis 2002;22:43–58.CrossRefGoogle ScholarPubMed
Chiu, B, Superina, R. Extrahepatic portal vein thrombosis is associated with an increased incidence of cholelithiasis. J Pediatr Surg 2004;39:1059–61.CrossRefGoogle ScholarPubMed
Ville de Goyet, J, Gibbs, P, Clapuyt, P. Original extrahilar approach for hepatic portal revascularization and relief of extrahepatic portal hypertension related to later portal vein thrombosis after pediatric liver transplantation. Long term results. Transplantation 1996;62:71–5.Google ScholarPubMed
Ville de Goyet, J, Alberti, D, Clapuyt, P. Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension. J Pediatr Surg 1998;33:597–601.CrossRefGoogle ScholarPubMed
Bambini, D A, Superina, R, Almond, P S. Experience with the Rex shunt (mesenterico-left portal bypass) in children with extrahepatic portal hypertension. J Pediatr Surg 2000;35:13–8; discussion 8–9.CrossRefGoogle ScholarPubMed
Utterson, E C, Shepherd, R W, Sokol, R J. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005;147:180–5.CrossRefGoogle ScholarPubMed
Kasai, M, Okamoto, A, Ohi, R. Changes of portal vein pressure and intrahepatic blood vessels after surgery for biliary atresiaJ Pediatr Surg 1981;16:152–9.CrossRefGoogle ScholarPubMed
Miyata, M, Satani, M, Ueda, T, Okamoto, E. Long-term results of hepatic portoenterostomy for biliary atresia: special reference to postoperative portal hypertension. Surgery 1974;76:234–7.Google ScholarPubMed
Ohi, R, Mochizuki, I, Komatsu, K, Kasai, M. Portal hypertension after successful hepatic portoenterostomy in biliary atresia. J Pediatr Surg 1986;21:271–4.CrossRefGoogle ScholarPubMed
Lilly, J R, Stellin, G. Variceal hemorrhage in biliary atresia. J Pediatr Surg 1984;19:476–9.CrossRefGoogle ScholarPubMed
Uflacker, R, Pariente, D M. Angiographic findings in biliary atresia. Cardiovasc Intervent Radiol 2004;27:486–90.CrossRefGoogle ScholarPubMed
Heurn, L W, Saing, H, Tam, P K. Portoenterostomy for biliary atresia: long-term survival and prognosis after esophageal variceal bleeding. J Pediatr Surg 2004;39:6–9.CrossRefGoogle ScholarPubMed
Sasaki, T, Hasegawa, T, Shimizu, Y. Portal hypertensive gastropathy after surgery for biliary atresia. Surg Today 2005;35:385–8.CrossRefGoogle ScholarPubMed
Smith, S, Wiener, E S, Starzl, T E, Rowe, M I. Stoma-related variceal bleeding: an under-recognized complication of biliary atresia. J Pediatr Surg 1988;23:243–5.CrossRefGoogle ScholarPubMed
Patriquin, H, Lafortune, M, Weber, A. Surgical portosystemic shunts in children: assessment with duplex Doppler US. Work in progress. Radiology 1987;165:25–8.Google ScholarPubMed
Iwao, T, Oho, K, Sakai, T. Noninvasive hemodynamic measurements of superior mesenteric artery in the prediction of portal pressure response to propranolol. J Hepatol 1998;28:847–55.CrossRefGoogle ScholarPubMed
Annet, L, Materne, R, Danse, E. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409–14.CrossRefGoogle ScholarPubMed
Taourel, P, Blanc, P, Dauzat, M. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology 1998;28:932–6.CrossRefGoogle ScholarPubMed
Giacomo, C, Tomasi, G, Gatti, C. Ultrasonographic prediction of the presence and severity of esophageal varices in children. J Pediatr Gastroenterol Nutr 1989;9:431–5.CrossRefGoogle ScholarPubMed
Patriquin, H, Tessier, G, Grignon, A, Boisvert, J. Lesser omental thickness in normal children: baseline for detection of portal hypertension. AJR Am J Roentgenol 1985;145:693–6.CrossRefGoogle ScholarPubMed
Sokal, E M, Hoorebeeck, N, Obbergh, L. Upper gastro-intestinal tract bleeding in cirrhotic children candidates for liver transplantation. Eur J Pediatr 1992;151:326–8.CrossRefGoogle ScholarPubMed
Zoli, M, Merkel, C, Magalotti, D. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology 1996;24:1047–52.CrossRefGoogle ScholarPubMed
Bosch, J, Bordas, J M, Rigau, J. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology 1986;6:667–72.CrossRefGoogle ScholarPubMed
Brensing, K A, Neubrand, M, Textor, J. Endoscopic manometry of esophageal varices: evaluation of a balloon technique compared with direct portal pressure measurement. J Hepatol 1998;29:94–102.CrossRefGoogle ScholarPubMed
Ueno, K, Hashizume, M, Ohta, M. Noninvasive variceal pressure measurement may be useful for predicting effect of sclerotherapy for esophageal varices. Dig Dis Sci 1996;41:191–6.CrossRefGoogle ScholarPubMed
El Atti, E A, Nevens, F, Bogaerts, K. Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension. Gut 1999;45:618–21.CrossRefGoogle ScholarPubMed
Eisen, G M, Eliakim, R, Zaman, A. The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy 2006;38:31–5.CrossRefGoogle Scholar
Lapalus, M G, Dumortier, J, Fumex, F. Esophageal capsule endoscopy versus Esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy 2006;38:36–41.CrossRefGoogle ScholarPubMed
Bismuth, H, Franco, D, Alagille, D. Portal diversion for portal hypertension in children. The first ninety patients. Ann Surg 1980;192:18–24.Google ScholarPubMed
Baert, A L, Fevery, J, Marchal, G. Early diagnosis of Budd–Chiari syndrome by computed tomography and ultrasonography: report of five cases. Gastroenterology 1983;84:587–95.Google ScholarPubMed
Ozsoylu, S, Kocak, N, Yuce, A. Propranolol therapy for portal hypertension in children. J Pediatr 1985;106:317–21.CrossRefGoogle ScholarPubMed
Groszmann, R J, Bosch, J, Grace, N D. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401–7.CrossRefGoogle Scholar
Vorobioff, J, Groszmann, R J, Picabea, E. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996;111:701–9.CrossRefGoogle ScholarPubMed
Groszmann, R J. The hepatic venous pressure gradient: has the time arrived for its application in clinical practice?Hepatology 1996;24:739–41.CrossRefGoogle ScholarPubMed
Feu, F, Garcia-Pagan, J C, BoschJ, et al J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056–9.CrossRefGoogle ScholarPubMed
Piscaglia, F, Gaiani, S, Donati, G. Doppler evaluation of the effects of pharmacological treatment of portal hypertension. Ultrasound Med Biol 1999;25:923–32.CrossRefGoogle ScholarPubMed
D'Amico, G, Pagliaro, L, Bosch, J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332–54.CrossRefGoogle ScholarPubMed
D'Amico, G, Pagliaro, L, Bosch, J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475–505.CrossRefGoogle Scholar
Imperiale, T F, Chalasani, N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001;33:802–7.CrossRefGoogle ScholarPubMed
Banares, R, Albillos, A, Rincon, D. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002;35:609–15.CrossRefGoogle ScholarPubMed
Groszmann, R J, Garcia-Tsao, G, Bosch, J. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–61.CrossRefGoogle ScholarPubMed
Gotoh, Y, Iwakiri, R, Sakata, Y. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy. J Gastroenterol Hepatol 1999;14:241–4.CrossRefGoogle ScholarPubMed
Sarin, S K, Lamba, G S, Kumar, M. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999;340:988–93.CrossRefGoogle ScholarPubMed
Schepke, M, Kleber, G, Nurnberg, D. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004;40:65–72.CrossRefGoogle ScholarPubMed
Kolster, C C, Rapa de Higuera, M, Carvajal, A. [Propranolol in children and adolescents with portal hypertension: its dosage and the clinical, cardiovascular and biochemical effects]. G E N 1992;46:199–207.Google Scholar
Shashidhar, H, Langhans, N, Grand, R J. Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study. J Pediatr Gastroenterol Nutr 1999;29:12–17.CrossRefGoogle ScholarPubMed
Ozsoylu, S, Kocak, N, Demir, H. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis. Turk J Pediatr 2000;42:31–3.Google ScholarPubMed
Lebrec, D, Poynard, T, Bernuau, J. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984;4:355–8.CrossRefGoogle ScholarPubMed
Pascal, J P, Cales, P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987;317:856–61.CrossRefGoogle ScholarPubMed
Hayes, P C, Davis, J M, Lewis, J A, Bouchier, I A. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990;336:153–6.CrossRefGoogle ScholarPubMed
Garcia-Pagan, J C, Feu, F, Bosch, J, Rodes, J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 1991;114:869–73.CrossRefGoogle ScholarPubMed
Merkel, C, Marin, R, Enzo, E. Randomized trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP). Lancet 1996;348:1677–81.CrossRefGoogle Scholar
Forrest, E H, Bouchier, I A, Hayes, P C. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis. J Hepatol 1996;25:909–15.CrossRefGoogle ScholarPubMed
Banares, R, Moitinho, E, Matilla, A. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 2002;36:1367–73.CrossRefGoogle ScholarPubMed
Lui, H F, Stanley, A J, Forrest, E H. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002;123:735–44.CrossRefGoogle ScholarPubMed
Chalasani, N, Boyer, T D. Primary prophylaxis against variceal bleeding: beta-blockers, endoscopic ligation, or both?Am J Gastroenterol 2005;100:805–7.CrossRefGoogle ScholarPubMed
Elizalde, J I, Moitinho, E, Garcia-PaganJC, et al JC, et al. Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients. J Hepatol 1998;29:789–95.CrossRefGoogle ScholarPubMed
Romero-Castro, R, Jimenez-Saenz, M, Pellicer-Bautista, F. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clin Gastroenterol Hepatol 2004;2:78–84.CrossRefGoogle ScholarPubMed
Hou, M C, Lin, H C, Liu, T T. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004;39:746–53.CrossRefGoogle ScholarPubMed
Rolando, N, Gimson, A, Philpott-Howard, J. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol 1993;18:290–4.CrossRefGoogle ScholarPubMed
Terblanche, J, Burroughs, A K, Hobbs, K E. Controversies in the management of bleeding esophageal varices (1). N Engl J Med 1989;320:1393–8.CrossRefGoogle Scholar
Moitinho, E, Escorsell, A, Bandi, J C. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626–31.CrossRefGoogle ScholarPubMed
McKiernan, P J. Treatment of variceal bleeding. Gastrointest Endosc Clin N Am 2001;11:789–812, viii.Google ScholarPubMed
Hill, I D, Bowie, M D. Endoscopic sclerotherapy for control of bleeding varices in children. Am J Gastroenterol 1991;86:472–6.Google ScholarPubMed
Mowat, A P. Liver disorders in childhood. 2nd ed. London: Buttersworth, 1987.Google Scholar
Bosch, J, Groszmann, R J, Garcia-Pagan, J C. Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial. Hepatology 1989;10:962–8.CrossRefGoogle ScholarPubMed
Walker, S, Stiehl, A, Raedsch, R, Kommerell, B. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology 1986;6:112–5.CrossRefGoogle ScholarPubMed
Kravetz, D, Bosch, J, Teres, J. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology 1984;4:442–6.CrossRefGoogle ScholarPubMed
Burroughs, A K, McCormick, P A, Hughes, M D. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 1990;99:1388–95.Google ScholarPubMed
Eroglu, Y, Emerick, K M, Whitingon, P F, Alonso, E M. Octreotide therapy for control of acute gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 2004;38:41–7.CrossRefGoogle ScholarPubMed
Heikenen, J B, Pohl, J F, Werlin, S L, Bucuvalas, J C. Octreotide in pediatric patients. J Pediatr Gastroenterol Nutr 2002;35:600–9.CrossRefGoogle ScholarPubMed
Zellos, A, Schwarz, K B. Efficacy of octreotide in children with chronic gastrointestinal bleeding. J Pediatr Gastroenterol Nutr 2000;30:442–6.CrossRefGoogle ScholarPubMed
Siafakas, C, Fox, V L, Nurko, S. Use of octreotide for the treatment of severe gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 1998;26:356–9.CrossRefGoogle ScholarPubMed
Mottet, C, Sieber, C C, Nauer, A. Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over dose-ranging echo-Doppler study. Hepatology 1998;27:920–5.CrossRefGoogle ScholarPubMed
Thapa, B R, Mehta, S. Endoscopic sclerotherapy of esophageal varices in infants and children. J Pediatr Gastroenterol Nutr 1990;10:430–4.CrossRefGoogle ScholarPubMed
Ho, H, Zuckerman, M J, Wassem, C. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices. Gastroenterology 1991;101:1642–8.CrossRefGoogle ScholarPubMed
Stiegmann, G. Endoscopic ligation of esophageal varices. Am J Surg 1988;156(3 pt 2):9B–12B.CrossRefGoogle Scholar
Hall, R J, Lilly, J R, Stiegmann, G V. Endoscopic esophageal varix ligation: technique and preliminary results in children. J Pediatr Surg 1988;23:1222–3.CrossRefGoogle ScholarPubMed
Stiegmann, G V, Goff, J S, Michaletz-Onody, P A. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527–32.CrossRefGoogle ScholarPubMed
Panes, J, Teres, J, Bosch, J, Rodes, J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988;33:454–9.CrossRefGoogle ScholarPubMed
Novis, B H, Duys, P, Barbezat, G O. Fibreoptic endoscopy and the use of the Sengstaken tube in acute gastrointestinal haemorrhage in patients with portal hypertension and varices. Gut 1976;17:258–63.CrossRefGoogle ScholarPubMed
Millar, A J, Brown, R A, Hill, I D. The fundal pile: bleeding gastric varices. J Pediatr Surg 1991;26:707–9.CrossRefGoogle ScholarPubMed
Iwatsuki, S, Starzl, T E, Todo, S. Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988;104: 697–705.Google ScholarPubMed
Rasinska, G, Wermenski, K, Rajszys, P. Percutaneous transsplenic embolization of esophageal varices in a 5-year-old child. Acta Radiol 1987;28:299–301.CrossRefGoogle Scholar
L'Hermine, C, Chastanet, P, Delemazure, O. Percutaneous transhepatic embolization of gastroesophageal varices: results in 400 patients. AJR Am J Roentgenol 1989;152:755–60.CrossRefGoogle ScholarPubMed
Johnson, S P, Leyendecker, J R, Joseph, F B. Transjugular portosystemic shunts in pediatric patients awaiting liver transplantation. Transplantation 1996;62:1178–81.CrossRefGoogle ScholarPubMed
Cao, S, Monge, H, Semba, C. Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: a case report. J Pediatr Surg 1997;32:125–7.CrossRefGoogle Scholar
Price, M R, Sartorelli, K H, Karrer, F M. Management of esophageal varices in children by endoscopic variceal ligation. J Pediatr Surg 1996;31:1056–9.CrossRefGoogle ScholarPubMed
Maksoud, J G, Goncalves, M E, Porta, G. The endoscopic and surgical management of portal hypertension in children: analysis of 123 cases. J Pediatr Surg 1991;26:178–81.CrossRefGoogle ScholarPubMed
Yachha, S K, Sharma, B C, Kumar, M, Khanduri, A. Endoscopic sclerotherapy for esophageal varices in children with extrahepatic portal venous obstruction: a follow-p study. J Pediatr Gastroenterol Nutr 1997;24:49–52.CrossRefGoogle Scholar
Fox, V L, Carr-Locke, D L, Connors, P J, Leichtner, A M. Endoscopic ligation of esophageal varices in children. J Pediatr Gastroenterol Nutr 1995;20:202–8.CrossRefGoogle ScholarPubMed
Sasaki, T, Hasegawa, T, Nakajima, K. Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia. J Pediatr Surg 1998;33:1628–32.CrossRefGoogle ScholarPubMed
McKiernan, P J, Beath, S V, Davison, S M. A prospective study of endoscopic esophageal variceal ligation using a multiband ligator. J Pediatr Gastroenterol Nutr 2002;34:207–11.CrossRefGoogle ScholarPubMed
Sarin, S K, Kumar, A. Sclerosants for variceal sclerotherapy: a critical appraisal. Am J Gastroenterol 1990;85:641–9.Google ScholarPubMed
Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. The Copenhagen Esophageal Varices Sclerotherapy Project. N Engl J Med 1984;311:1594–600.
Westaby, D, Macdougall, B R, Williams, R. Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology 1985;5:827–30.CrossRefGoogle ScholarPubMed
Infante-Rivard, C, Esnaola, S, Villeneuve, J P. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology 1989;96:1087–92.CrossRefGoogle ScholarPubMed
Vane, D W, Boles, E T, Clatworthy, HW Jr. Esophageal sclerotherapy: an effective modality in children. J Pediatr Surg 1985;20:703–7.CrossRefGoogle ScholarPubMed
Hassall, E, Berquist, W E, Ament, M E. Sclerotherapy for extrahepatic portal hypertension in childhood. J Pediatr 1989; 115:69–74.CrossRefGoogle ScholarPubMed
Polson, R J, Westaby, D, Gimson, A E. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. Hepatology 1989;10:279–82.CrossRefGoogle ScholarPubMed
Seidman, E, Weber, A M, Morin, C L. Spinal cord paralysis following sclerotherapy for esophageal varices. Hepatology 1984;4:950–4.CrossRefGoogle ScholarPubMed
Helpap, B, Bollweg, L. Morphological changes in the terminal oesophagus with varices, following sclerosis of the wall. Endoscopy 1981;13:229–33.CrossRefGoogle Scholar
Gerhartz, H H, Sauerbruch, T, Weinzierl, M, Ruckdeschel, G. Nosocomial septicemia in patients undergoing sclerotherapy for variceal hemorrhage. Endoscopy 1984;16:129–30.CrossRefGoogle ScholarPubMed
Carr-Locke, D L, Sidky, K. Broncho-oesophageal fistula: a late complication of endoscopic variceal sclerotherapy. Gut 1982;23: 1005–7.CrossRefGoogle ScholarPubMed
Tabibian, N, Schwartz, J T, Smith, J L, Graham, D Y. Cardiac tamponade as a result of endoscopic sclerotherapy: report of a case. Surgery 1987;102:546–7.Google ScholarPubMed
Greenholz, S K, Hall, R J, Sondheimer, J M. Manometric and pH consequences of esophageal endosclerosis in children. J Pediatr Surg 1988;23(1 pt 2):38–41.CrossRefGoogle Scholar
Ohnuma, N, Takahashi, H, Tanabe, M. Endoscopic variceal ligation using a clipping apparatus in children with portal hypertension. Endoscopy 1997;29:86–90.CrossRefGoogle ScholarPubMed
Saeed, Z A. The Saeed Six-Shooter: a prospective study of a new endoscopic multiple rubber-band ligator for the treatment of varices. Endoscopy 1996;28:559–64.CrossRefGoogle ScholarPubMed
Laine, L, Cook, D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995;123:280–7.CrossRefGoogle ScholarPubMed
Sarin, S K, Govil, A, Jain, A K. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol 1997;26:826–32.CrossRefGoogle ScholarPubMed
Fonkalsrud, E W. Surgical management of portal hypertension in childhood: long-term results. Arch Surg 1980;115:1042–5.CrossRefGoogle ScholarPubMed
Alvarez, F, Bernard, O, Brunelle, F. Portal obstruction in children. II. Results of surgical portosystemic shunts. J Pediatr 1983;103:703–7.Google ScholarPubMed
Mitra, S K, Rao, K L, Narasimhan, K L. Side-to-side lienorenal shunt without splenectomy in noncirrhotic portal hypertension in children. J Pediatr Surg 1993;28:398–401; discussion 402.CrossRefGoogle ScholarPubMed
Prasad, A S, Gupta, S, Kohli, V. Proximal splenorenal shunts for extrahepatic portal venous obstruction in children. Ann Surg 1994;219:193–6.CrossRefGoogle ScholarPubMed
Evans, S, Stovroff, M, Heiss, K, Ricketts, R. Selective distal splenorenal shunts for intractable variceal bleeding in pediatric portal hypertension. J Pediatr Surg 1995;30:1115–18.CrossRefGoogle ScholarPubMed
Shun, A, Delaney, D P, Martin, H C. Portosystemic shunting for paediatric portal hypertension. J Pediatr Surg 1997;32:489–93.CrossRefGoogle ScholarPubMed
Dasgupta, R, Roberts, E, Superina, R A, Kim, P C. Effectiveness of Rex shunt in the treatment of portal hypertension. J Pediatr Surg 2006;41:108–12; discussion 112.CrossRefGoogle ScholarPubMed
Terblanche, J, Burroughs, A K, Hobbs, K E. Controversies in the management of bleeding esophageal varices (2). N Engl J Med 1989;320:1469–75.CrossRefGoogle Scholar
Huang, Y H, Yeh, H Z, Chen, G H. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000;52:160–7.CrossRefGoogle ScholarPubMed
Greenwald, B D, Caldwell, S H, Hespenheide, E E. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol 2003;98:1982–8.CrossRefGoogle ScholarPubMed
Heyman, M B, LaBerge, J M, Somberg, K A. Transjugular intrahepatic portosystemic shunts (TIPS) in children. J Pediatr 1997;131:914–19.CrossRefGoogle ScholarPubMed
Hackworth, C A, Leef, J A, Rosenblum, J D. Transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Radiology 1998;206:109–14.CrossRefGoogle ScholarPubMed
Heyman, M B, LaBerge, J M. Role of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension in pediatric patients. J Pediatr Gastroenterol Nutr 1999;29:240–9.CrossRefGoogle ScholarPubMed
Vignali, C, Bargellini, I, Grosso, M. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 2005;185:472–80.CrossRefGoogle ScholarPubMed
Shneider, B, Emre, S, Groszmann, R. Portal hypertension in children: expert pediatric opinion on the report of the Baveno IV consensus workshop on the methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant 2006;10:893–907.CrossRefGoogle ScholarPubMed
Superina, R, Shneider, B, Emre, S. Surgical guidelines for the management of extra-hepatic portal vein obstruction. Pediatr Transplant 2006;10:908–13.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Portal Hypertension
    • By Benjamin L. Shneider, M.D., Visiting Professor, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania; Director of Pediatric Hepatology, Department of Pediatrics/Gastroenterology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.009
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Portal Hypertension
    • By Benjamin L. Shneider, M.D., Visiting Professor, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania; Director of Pediatric Hepatology, Department of Pediatrics/Gastroenterology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.009
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Portal Hypertension
    • By Benjamin L. Shneider, M.D., Visiting Professor, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania; Director of Pediatric Hepatology, Department of Pediatrics/Gastroenterology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.009
Available formats
×